Global Blood Therapeutics Investor Relations Material
Latest events
Investor Conference 2022
Global Blood Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Global Blood Therapeutics Inc
Access all reports
Global Blood Therapeutics Inc. is a biopharmaceutical company focused on developing and delivering treatments for blood disorders. The company is primarily known for its work in addressing sickle cell disease, offering innovative therapies aimed at improving the quality of life for patients suffering from this and other blood-related conditions. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
GBT
Country
🇺🇸 United States